Events|

SHL to speak and exhibit at the Prefilled Syringe Seminar 2015 Tokyo

Shl Medical Conceptual Rainbow Amber Auto Injectors

SHL will be attending and exhibiting at the upcoming Guide for Prefilled Syringe Seminar 2015 in Tokyo, Japan, where Executive Director of Business Development Thomas Schönknecht has been invited to speak on the topic of “Insight Into the Changing World of Auto-Injectors: Trends, Partnerships and Key Learnings.”

As the prevalence of chronic diseases rises and the emergence of biologics grow, the demand for self-administered drug delivery devices like autoinjectors and pen injectors continues to increase rapidly. Although the larger share of the global autoinjector market resides in North America and Europe, a high growth in Asia Pacific is soon to be expected. Leading the way are players such as Japan and Korea, who are either in the midst of developing an autoinjector product or have already launched one. For example, the Enbrel® Auto-Injector was officially introduced to the Japanese market in 2013.

Commenting on this year’s attendance, Thomas Schönknecht said: “We feel very privileged to be invited to the 2015 Prefilled Syringe Seminar in Tokyo, and I am personally very excited to speak at this year’s event. SHL sees Japan as one of the fastest emerging markets in Asia for self-administered devices like autoinjectors and pen injectors, making it even more vital for us to connect and share our experiences and learnings with key biopharmaceutical players in the region. With Japan so close to our main manufacturing sites in Taiwan, we encourage potential customers to visit our facilities where we can better showcase the capabilities and capacities available in-house.”

About SHL

SHL Group is a world-leading solution provider in the design, development and manufacturing of advanced drug delivery devices such as autoinjectors, pen injectors and advanced inhaler systems. We also offer core competencies and services in the fields of medtech and patient care solutions. With locations in Taiwan, Switzerland, Sweden, China and the US, our experienced engineers and designers develop product enhancements as well as breakthrough drug delivery and patient care solutions for pharma and biotech clients globally. Significant investment in R&D has enhanced our broad pipeline of next-generation drug delivery systems that support ongoing innovations in drug development and digital healthcare. This includes advanced reusable and disposable injectors that can accommodate high volume and high viscosities and can be enhanced through digital implementations.

With over 4,800 employees worldwide, SHL Group consists of several distinct group companies:

SHL Medical designs, develops and manufactures advanced drug delivery devices, as well as provides final assembly, labeling and packaging services for leading pharmaceutical and biotech companies across the globe.

SHL Healthcare develops and manufactures equipment solutions for home, hospital and long term care use.

SHL Technologies provides contract manufacturing and engineering services for the production of complex medtech and industrial products.

For additional information, visit www.shl.group

 

Share:

Related News